Skin hydration study in people with sickle cell
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at how hydrated your skin is in people with sickle cell disease. It aims to better understand skin-related changes, which may help doctors monitor health and treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sickle cell disease (types like SS, SC, S beta-thalassemia, SD, or SOArab)
- You are at least 12 years old
- You can legally consent (or have a legal guardian who can) for all study steps
- You are not taking an experimental medication as part of another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
This study asks adults with sickle cell disease about what they eat and their eating routines. The goal is to understand diet patterns in sickle cell and how they may relate to health, which could help future care and guidance.
This study collects blood and urine samples from adults to help researchers understand diseases affecting blood vessels. Your donation helps scientists develop better treatments.
This study is a registry that collects information about people living with sickle cell disease. It may help researchers better understand sickle cell types in Germany, Austria, and Switzerland and support future research and care.
This study looks at long-term health effects after curative treatments for sickle cell disease, such as bone marrow transplant. Your participation helps researchers understand what changes over time after treatment, and what might need monitoring or care.
This trial tests an investigational drug called DISC-3405 in people with sickle cell disease (SCD) to see if it is safe and how it affects your body. It may be an option if you have certain SCD complications or lab results.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.